In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …

Hastening posttransplantation immune reconstitution is a key challenge in human leukocyte
antigen (HLA)–haploidentical hematopoietic stem-cell transplantation (HSCT). In …

CD8 + T cells have a crucial role in resistance to pathogens and can kill malignant cells;
however, some critical functions of these lymphocytes depend on helper activity provided by a …

Abstract Concepts of cell-cell interactions in adaptive immunity have alternated between the
simple and the complex. The notion that one population of small, circulating lymphocytes is …

Heat shock proteins (HSPs) derived from tumors or virally infected cells can stimulate
antigen-specific CD8 + T cell responses in vitro and in vivo. Although this antigenicity is known to …

Oil-in-water adjuvants have been shown to improve immune responses against pandemic
influenza vaccines as well as reduce the effective vaccine dose, increasing the number of …

Vaccines against influenza viruses with pandemic potential, including H5N1, are under
development. Because of a lack of preexisting immunity to these viruses, adjuvants (immune …

Proactive priming before the next pandemic could induce immune memory responses to
novel influenza antigens. In an open-label study, we analyzed B cell memory and antibody …

Immune responses to vaccination are tested in clinical trials. This process usually requires
years especially when immune memory and persistence are analyzed. Markers able to …

Measuring immune correlates of disease acquisition and protection in the context of a clinical
trial is a prerequisite for improved vaccine design. We analysed binding and neutralizing …